IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.856
AS - Asia 2.263
EU - Europa 1.788
SA - Sud America 592
AF - Africa 174
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.774
SG - Singapore 1.006
CN - Cina 592
BR - Brasile 502
IT - Italia 412
SE - Svezia 345
HK - Hong Kong 279
RU - Federazione Russa 255
DE - Germania 226
UA - Ucraina 163
VN - Vietnam 159
CI - Costa d'Avorio 136
FI - Finlandia 121
GB - Regno Unito 97
IN - India 51
CA - Canada 44
FR - Francia 38
AR - Argentina 37
ID - Indonesia 33
MX - Messico 29
BD - Bangladesh 24
NL - Olanda 23
PL - Polonia 23
IE - Irlanda 22
JP - Giappone 18
TR - Turchia 16
ZA - Sudafrica 16
ES - Italia 14
IQ - Iraq 11
LT - Lituania 11
VE - Venezuela 11
AT - Austria 10
IR - Iran 10
CO - Colombia 9
PY - Paraguay 9
BE - Belgio 8
EC - Ecuador 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
AZ - Azerbaigian 6
CL - Cile 6
CZ - Repubblica Ceca 6
MA - Marocco 6
KR - Corea 5
PE - Perù 5
AU - Australia 4
BY - Bielorussia 4
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
RO - Romania 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 9.681
Salva come PNG Salva come JPEG
Città #
Singapore 541
Ashburn 469
Fairfield 414
Chandler 390
Jacksonville 371
Woodbridge 348
Hong Kong 279
Nyköping 247
Houston 245
Bari 214
Cambridge 184
Ann Arbor 173
Beijing 168
Seattle 162
Abidjan 136
Dallas 136
Wilmington 136
New York 96
Roxbury 95
Lawrence 92
Los Angeles 87
Nanjing 87
Munich 69
Des Moines 65
Ho Chi Minh City 57
Boardman 56
Brooklyn 48
São Paulo 48
Princeton 42
Inglewood 40
Hanoi 38
Buffalo 37
Dearborn 37
San Diego 33
Shenyang 32
Santa Clara 29
Jakarta 26
London 26
Nanchang 26
Pune 23
Dublin 22
Warsaw 22
Changsha 19
Chicago 18
Guangzhou 18
Turku 18
Hebei 17
Helsinki 17
Jiaxing 17
Moscow 17
Montreal 16
Johannesburg 15
Noicattaro 15
Phoenix 15
Tokyo 15
Atlanta 14
Tianjin 14
Toronto 14
Trani 14
Denver 13
Mexico City 13
Rome 13
Belo Horizonte 12
Paris 12
Redwood City 12
San Francisco 12
Falkenstein 11
Orem 11
Rio de Janeiro 11
Chennai 10
Frankfurt am Main 10
Hefei 10
Manchester 10
Stockholm 10
Boydton 9
Orta Nova 9
Salvador 9
Wuhan 9
Brussels 8
Council Bluffs 8
Poplar 8
Salt Lake City 8
Ankara 7
Ardabil 7
Boston 7
Brasília 7
Curitiba 7
Falls Church 7
Haiphong 7
Kunming 7
Melito Di Napoli 7
Milan 7
Norwalk 7
Shanghai 7
Tashkent 7
The Dalles 7
Baku 6
Brno 6
Campinas 6
Charlotte 6
Totale 6.479
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 194
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 185
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 180
Sclerostin stimulates angiogenesis in human endothelial cells 152
TRAIL effect on osteoclast formation in physiological and pathological conditions 151
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 143
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 133
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 131
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 129
Cellular mechanisms of multiple myeloma bone disease 127
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 127
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 126
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 124
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 124
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 123
Osteogenic differentiation of dental follicle stem cells. 119
TRAIL is involved in human osteoclast apoptosis 114
Another link between bone and immune system: LIGHT 111
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 110
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 110
THE ROLE OF LIGHT ON BONE REMODELING 109
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 107
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 107
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 106
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 106
Osteoblast Apoptosis in Periodontal Disease: Role of TNF-related apoptosis-inducing ligand 106
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 103
The effect of Irisin on bone cells in vivo and in vitro 103
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 102
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 102
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 102
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 100
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 99
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 98
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 98
The Role of LIGHT in Multiple Myeloma-Bone Disease 98
Myeloma cells suppress osteoblasts through sclerostin secretion 98
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 97
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 95
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 95
DCR3 involvement in multiple myeloma bone disease 94
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 94
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 94
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 94
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 92
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 92
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 91
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 88
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 87
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 86
Circulating levels of cathepsin-k in multiple myeloma patients 86
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 85
Myeloma cells induce osteoblast suppression through sclerostin secretion 85
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 84
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 84
Mechanism of Bone Disease in Prader-Willi Syndrome 84
DcR3 involvement in multiple myeloma bone disease 82
Bone Cells 82
Irisin and Secondary Osteoporosis in Humans 80
Dental pulp stem cells: osteogenic differentiation and genes expression 79
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 78
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 77
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 75
High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome 74
null 74
LIGHT: another link between bone and immune system 74
Osteoclast apoptosis: Role of TRAIL and its receptors 72
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 71
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 71
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 71
null 71
The role of light (TNFSF14) on bone remodeling 69
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease 69
LIGHT: a new potential molecule involved in bone loss 68
Osteogenic properties of human dental pulp stem cells 68
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 68
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 67
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 66
Inflammatory Cells in Diffuse Large B Cell Lymphoma 66
Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome 65
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 65
Osteoblast apoptosis in periodontal disease: role of TRAIL 65
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 64
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 64
null 63
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 63
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 63
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 61
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 61
Evaluation of serum levels of cathepsin k in multiple myeloma patients 60
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 60
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 60
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 59
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 58
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 57
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 57
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 57
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 57
IN VITRO EVALUATION OF OSTEOGENIC PROPERTIES OF HUMAN DENTAL PULP STEM CELLS 55
DcR3 involvement in multiple myeloma bone disease 55
Totale 9.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021513 0 0 0 0 0 48 87 54 111 114 65 34
2021/2022802 27 108 5 32 26 50 28 35 128 40 134 189
2022/20231.144 166 122 64 85 140 134 22 131 228 5 18 29
2023/2024425 45 84 12 27 35 114 8 4 1 27 25 43
2024/20252.061 127 27 141 70 47 201 285 165 70 134 267 527
2025/20262.498 634 213 430 510 504 207 0 0 0 0 0 0
Totale 9.909